Immuneering Corp (IMRX) — Financial Flexibility Index
Immuneering Corp (IMRX) has a Financial Flexibility Index of -0.92x as of September 2025. Free cash flow of $-11.97 Million (operating CF $-11.98 Million minus capex $7.25K) represents -1% of total liabilities ($13.08 Million). Check IMRX tangible net worth ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Immuneering Corp Financial Flexibility Index (2019–2024)
Historical Financial Flexibility Index trend for Immuneering Corp across 6 annual periods. For the full cash flow conversion analysis, see IMRX cash generation efficiency.
Annual Financial Flexibility Index for Immuneering Corp (2019–2024)
Year-by-year free cash flow to debt coverage for Immuneering Corp. Explore Immuneering Corp cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.85x | $-54.91 Million | $-55.00 Million | $11.33 Million | ▼ -19.7% |
| 2023 | -4.05x | $-48.63 Million | $-48.97 Million | $12.01 Million | ▼ -16.9% |
| 2022 | -3.46x | $-43.36 Million | $-44.10 Million | $12.52 Million | ▼ -20.7% |
| 2021 | -2.87x | $-30.79 Million | $-30.85 Million | $10.72 Million | ▼ -1100.3% |
| 2020 | -0.24x | $-14.57 Million | $-14.62 Million | $60.90 Million | ▼ -11.6% |
| 2019 | -0.21x | $-4.42 Million | $-4.44 Million | $20.63 Million | — |